News Agency of Nigeria
Youths, others advocate utilisation of technology, innovation for HIV prevention

Youths, others advocate utilisation of technology, innovation for HIV prevention

 

By Justina Auta

Some youth groups and other stakeholders have called for the use of technology and innovation to promote HIV prevention, meet Sustainable Development Goals (SDGs) and “95-95-95” targets of ending AIDS by 2030.

They made the call at the closing ceremony of the 2024 Nigeria HIV Prevention Conference organised by the National Agency for the Control of AIDS (NACA) and others on Thursday in Abuja.

Ms Elizabeth Williams, representing 170 participating youths, stressed the need for strengthening multi-sectoral response, prioritising the needs of adolescents and young people, and their inclusion in national HIV prevention programmes.

“We recognise the transformative potential of science, technology, and innovation, in driving sustainable development and promoting HIV prevention among youths evidenced by the YAHNaija story in Nigeria.

“We urge all stakeholders to harness digital technologies and social media platforms to deliver HIV prevention messages, promote healthy behaviours, and facilitate access to testing and support services for adolescents and young people,” she said.

She called for a multi-stakeholder approach to the development of mobile health applications and online platforms for HIV education, self-testing, adherence support, and virtual counselling services.

“These should be tailored to the needs and preferences of adolescent and young people living with HIV, including key populations.

“We advocate for bridging the digital divide in the context of HIV prevention, recognising the transformative potential of technology in reaching vulnerable populations,” she said.

Williams also called on the government to sustain the multi-sectoral response for HIV prevention and the integration of sustainable HIV prevention strategies.

“We, the Nigerian adolescents, and youths, including Persons Living with HIV and the Key Population, stand united in our commitment to working towards a brighter and more sustainable future for our country and the African continent.

“We call upon the government and all stakeholders to join hands with us in advancing the sustainable development goals and realising the aspirations of the 95%-95%-95% targets by 2030,” she said.

Dr Temitope Ilori, Director General, NACA, reaffirmed his commitment towards partnering with all stakeholders to end HIV in Nigeria.

“We are ready to drive the accelerated decline in HIV infection and we are going to strengthen our multi-sectoral engagement,” she said.

Also, Dr Leo Zekeng, Country Director, UNAIDS, said implementing the recommendations, more advocacies, resource mobilisation and support would ensure an end to HIV in Nigeria.

He said: “I strongly believe that it is possible for us to reduce those new infections. I strongly believe that by working together we can end AIDS in this beautiful country.”

Ms Funmi Adesanya, Country Coordinator, President’s Emergency Plan for AIDS Relief (PEPFAR), urged the participants to ensure that they implement, and cascade lessons learnt to others to end HIV/AIDs in Nigeria.

“You all are going to be the change agents that are going to bring innovation at a grassroots level for the Local Government Area level and for the state level across your communities.

“The various faith networks really ensure that we close the tabs on new HIV infections,” she said. (NAN)(www.nannews.ng)

Edited by Kadiri Abdulrahman and Abiemwense Moru

Foundation, CSOs express concern over WHO pandemic agreement proposal

Foundation, CSOs express concern over WHO pandemic agreement proposal

 

By Justina Auta

The AIDS Healthcare Foundation, (AHF) and some Civil Society Organisations (CSOs) have called for a readjustment of the current draft of the WHO pandemic agreement particularly in developing nations.

They specifically called for the readjustment of the draft of the World Health Organisation (WHO) pandemic agreement to strengthen the international community’s ability to detect and respond to future pandemics threat in developing nations.

They made the call while addressing newsmen in Abuja ahead of the finalisation of the WHO agreement Draft in May 2024.

Dr Echey Ijezie, Country Programme Director, AHF, said that the proposed text had been significantly watered down through the negotiation process and is filled with platitudes, anaemic in obligations, and devoid of any accountability.

“We expressed profound concern that developed nations have vehemently defended the private interest of pharmaceutical companies over the collective common interest of achieving global health security in a sustainable and equitable manner.

“Such disregard has been observed in the proposed compromise for the WHO Pathogen Access and Benefit-Sharing System, which the Lancet has described as not only “shameful, unjust, and inequitable” but also “ignorant.” he said.

Ijezie added that to ensure its objectivity and effectiveness, the agreement should consider establishing an independent oversight body that is “politically, financially, technically and operationally independent of the WHO and donors.”

“Compliance, however, has been largely ignored by all parties and brushed under the rug throughout the negotiations.

“This is reflected in the current text, which does not mention the word compliance even once.”

“To this end, we echo the concerns of the Panel for a Global Public Health Convention that the idea of a Compliance and Implementation Committee should not have been dropped from the text,” he said.

He also added that the current text did not include effective engagement with CSOs and other nongovernmental actors in the agreement.

Also, Dr Abdulkadir Ibrahim, National Coordinator Network of People Living with HIV/AIDS (NEPWHAN), noted the role of CSOs as critical partners to global responses on pandemics and related issues.

“We are calling on WHO to restore the position of the civil society strongly and urgently with clear engagement and define the core role that the CSOs will put in place as we move ahead in putting the agenda for pandemic preparedness.

“The value it will add, will help in demand creation to sensitise, educate and empower people with knowledge about some of these things and what happened in the past, where we are and where we should be going,” he said.

Also speaking, Rommy Mom, the President Lawyers Alert, said pandemic responses should be “Right based” where the world can implement Rights policies especially in the global south.

Mom called for compliance and monitoring.

“When-we approach the issues of pandemics, low-income countries find it difficult to access drugs because people can’t afford them.

“But if we look at it from a human rights angle, people should have access to lifesaving medications,” he said.

Hajia Hauwa Mustapha, Deputy National Chairperson, Alliance for Covid-19 and Beyond and Focal Person, Climate Change, Nigeria Labour Congress (NLC), explained that pandemics do not occur overnight.

“And one of the key processes that leads to some of the health pandemics we witness in the world is climate change.

“So it is important for us, while addressing pandemic as an immediate emergency, to also engage the causative factors, which is climate change and specifically about what we produce and consume.”

Amber Itohan-Erinmwinhe, Executive Secretary, Nigerian Network of Religious Leaders Living with and affected by HIV/AIDS (NINERELA+) suggested that the core role of CSOs should be repositioned and re-defined in the engagement of pandemic responses.

Mrs Chizoba Ogbeche, Vice President, Zone D, Nigeria Association of Women Journalists, (NAWOJ), stressed the need to protect women and children against pandemics or any harm. (NAN)

Edited by Kadiri Abdulrahman/Sadiya Hamza

Malaria prevention: Monoclonal antibodies offering additional hope

Malaria prevention: Monoclonal antibodies offering additional hope

 

 

By Vivian Ihechu, News Agency of Nigeria (NAN)

As Nigeria and other African countries  continue to  seek ways to prevent malaria, monoclonal antibodies (mAbs) are offering a strong  hope.

Dr Kayla Andrews, the  Scientific Programme Leader at  Bill and Melinda Gates Medical Research Institute (MRI), is giving this assurance.

Andrews spoke about the Institute’s efforts in the clinical development of its monoclonal antibody (mAbs) – the Gates MRI MAM01

According to Andrews, MAM01 is the institute’s prophylactic antibody candidate for prevention of malaria caused by plasmodium falciparum.

“mAbs represents one of the most important medical innovations in modern pharmacology,’’ she says.

Prophylactic means a medicine or course of action used to prevent a disease.

Andrews says due to the limitations of existing control strategies, coupled with the impact malaria has on children in low and middle-income countries, Gates MRI initiated  the development of the monoclonal antibody (mAb).

The scientist says the  “antibody” is under clinical development.

According to Gates MRI Fact Sheet, Malaria is a mosquito-borne illness that has afflicted people around the world for thousands of years.

It is a preventable and treatable disease; yet, in 2022 ,there were an estimated 249 million new malaria cases worldwide and approximately 608,000 deaths in 85 countries.

Sub-Saharan Africa accounted for 94 per cent of malaria cases and 95 per cent of malaria deaths in 2022.

Children under the age of five years accounted for 80 per cent of all malaria deaths in the region.

For two years, the COVID-19 pandemic affected the fight against malaria, disrupting prevention and treatment services and leading to additional 63,000 malaria deaths and  additional 13 million cases.

 

 

Andrews notes that malaria can be  prevented by avoiding mosquito bites, taking preventive medicines, sleeping under long-lasting insecticide-treated bed nets, and through vector-control interventions, among other means.

“New malaria vaccines have shown to significantly reduce malaria, especially the more severe and deadly, among children.

“However, new and better tools are desperately needed,” she says.

Recently, the World Health Organization recommended that children from five months of age in regions with moderate-to-high plasmodium falciparum malaria transmission should be given the RTS,S/AS01 (MosquirixTM) vaccine to reduce malaria disease burden.

Analysts are, however, worried that  modest efficacy and restricted supply may limit the impact.

While praising successes in efforts at preventing malaria, Andrews believes that a huge sense of urgency is still needed to generate new tools in the fight against malaria.

According to her, Gates MRI is developing the prophylactic mAb in partnership with Atreca, a biotechnology company.

She hopes that “a mAb can provide lengthened protection as compared to small molecules”.

Dr Kayla Andrews

 

She is hopeful  that the monoclonal antibody will complement other established preventive strategies.

“It has been exciting; first, with the rollout of the very first world malaria vaccine, RTS,S/AS01, then the new R21 vaccine.

“We also have, of course, our insecticide-treated nets, the scale of seasonal prevention for children that are at high risk of severe malaria.

“With the effective tools that we have in our arsenal, the monoclonal antibody is a complementary tool in the fight against malaria.’’

Giving an insight into monoclonal antibodies, she explains  that human bodies naturally produce antibodies to fight infections.

According to her, this  happens any time a human being gets infected with any pathogen,  whether COVID or RSV, Ebola or flu.

According to Andrews, for the diseases that immune systems have difficulty overcoming — as with COVID-19 — researchers are developing mAbs which, when injected, will combat  the infection and remain in the body for months to tackle re-infections.

“Monoclonal antibodies usually have fewer off-target effects than small-molecule drugs in most patients. They can be produced on a large scale in bioreactors.

“Monoclonal antibodies are, in most cases, derived from individuals that have developed antibodies to fight against the infection.

“What we tried to do is to select a trial of these antibodies and select the potent antibody – the one that elicits the strongest protections – and we select these really potent antibodies for further optimisation, for development to make them into a product.

“Another way of thinking about it is: a monoclonal antibody is something that is naturally produced, and we will use, try and take the best one that we can find and make it even stronger.

“There is a lot that goes into that, in terms of making sure that it has the efficacy that we want and the duration of protection that we want,’’ she explains.

Andrews says  there are three monoclonal antibodies currently in clinical development for the prevention of plasmodium falciparum malaria infection.

“Two of them are the NIH antibodies, CIS43LS, and the third is our antibody at the Gates MRI, the MAM01.

“Each of these three antibodies targets slightly different epitopes, and they have slightly different targets on where they bind the malaria parasite.

“The MAM01 MRI antibody is being worked on in partnership with Atreca, and it has been  licensed,” she adds.

The scientist discloses that the Gates MRI is currently evaluating the safety, efficacy and pharmacokinetics of MAM01 in a phase 1 first-in-human clinical trial in adults.

“Once the safety, tolerability, pharmacokinetics and efficacy of MAM01 are established in adults, the goal will be to conduct clinical studies in the most vulnerable population (children older than three months and younger than five years old) to assess the safety and ability of MAM01 to prevent P. falciparum infection.

“We finished the development of this antibody and filed our IND, our investigation of new drug application.

“We are in phase one study now. It is ongoing at the University of Maryland, to show the safety of the antibody in certain doses.

`’The reason for this is that we want to make sure that our antibody is safe and that it is providing protection,” Andrews says.

She emphasises that all tools to fight malaria are complementary.

Addressing the uniqueness of monoclonal antibodies, she says: “ What is unique as compared to a vaccine is that, generally speaking, vaccines require your body to mount an immune response.

“This takes time. This also requires multiple doses of the vaccine.

“For a monoclonal antibody, the idea is that this will be a single touch point with the healthcare system, a single shot that can provide near immediate protection –  near immediate because, if it is IV, it is protection that day, but if it is administered intramuscularly or subcutaneously, then, the time to the maximum concentration in blood takes about  a week.

“This is much shorter than the time that it takes for protection for a vaccine.

“It is  well accepted that there is a gap in interventions for pregnant women; so, this could be a potential use case for a monoclonal antibody,” she says.

Andrews adds that children with anaemia can be a potential use case for a monoclonal antibody.

According to Andrews, while the actual  duration of the monoclonal antibody  protection has not been established, the target is that a single injection prior to the rainy season will be able to give coverage that is beneficial. (NANFeatures) www.nannews.ng

Edited by Ijeoma Popoola

*** If used. Please credit the writer and the agency **

Red Cross sensitises 1.4m people to dangers of Lassa fever

Red Cross sensitises 1.4m people to dangers of Lassa fever

By Franca Ofili

The Nigerian Red Cross Society (NRCS) says it will sensitise about1.4 million people to the dangers of Lassa fever.

The sensitisation would also be on preventive measures and where to access treatment.

The Secretary General of the society, Mr Abubakar Kende, said this in Abuja on Wednesday during the celebration of the World Red Cross Day.

The Red Cross Day celebration is with the theme, ‘Keeping Humanity Alive”.

“The most current thing which we are doing right now is Lassa Fever Intervention.

“We intend to sensitise at least 1.4 million people about the dangers of the virus, how to avoid it and where to access treatment if they suspect they are infected

“As things stand now, 150 people have died of an outbreak of Lassa Fever in 27 states including the Federal Capital Territory.”

He said that 5,295 lassa fever cases have been reported in 2024, in Nigeria.

According to him, the worst affected states are Bauchi, Taraba, Edo, Ondo, Plateau, Benue, Cross River, Rivers, Anambra, and Ebonyi States.

He said that the society’s volunteers would work with communities in some particular Local Government Areas to reduce rat infestation.

According to him, the volunteers will show communities how to provide immediate help for suspected cases.(NAN)(www.nannews.ng)

Edited by Abiemwense Moru

Group, Liverpool school partner on obstetric training for doctors

Group, Liverpool school partner on obstetric training for doctors

By Aderogba George

Wellbeing Foundation Africa (WBFA) and Liverpool School of Tropical Medicine have entered into partnership to strengthen obstetric skills of resident doctors in Nigeria.

Mrs Adanna Maduka, Director, Policy, Partnerships and Grants, WBFA, said in a statement issued in Abuja on Wednesday.

She said that the partnership was aimed at improving the capacity of the National Postgraduate Medical College of Nigeria (NPMCN) to deliver the advanced obstetrics and surgical skills training to resident doctors.

The project, she said, would establish two centres of excellence in northern and southern Nigeria where the training would be delivered.

“The Emergency Obstetrics and Quality of Care (EmOC&QoC) Unit of the Liverpool School of Tropical Medicine (LSTM) is proud to announce its collaboration with WBFA in an effort to enhance emergency obstetric and newborn care (EmONC) in Nigeria.

“This project is funded through the Global Health Workforce Programme, which is funded by the UK Department of Health and Social Care (DHSC).

“It is managed by Tropical Health and Education Trust (THET) for the benefit of the UK and partner country health sectors.

“The partnership is aimed at bolstering the capacity of the National Postgraduate Medical College of Nigeria (NPMCN) to deliver the Advanced Obstetrics and Surgical Skills training to resident doctors.

“The project will establish two centres of excellence in northern and southern Nigeria where the training course will be delivered,” she said.

She quoted the principal investigator of the project and lead of the LSTM’s EmOC&QoC Unit, Prof. Charles Ameh, as saying the unit has extensive experience in delivering maternal and newborn health capacity.

She said that the unit has the capacity to strengthening interventions in Nigeria and across sub-Saharan Africa, adding that the project offers them the opportunity to further expand impact in Nigeria.

This, she said, would give the organisation opportunity to further tackle high maternal and newborn deaths by training local doctors in life-saving skills, for the care of pregnant women and their newborn babies.

The statement also quoted Mrs Toyin Saraki, Founder/President of WBFA expressing her organisation’s commitment to the project.

She stated that WBFA is honoured to partner LSTM and THET in the endeavour, adding that improve access to quality EmONC services in Nigeria.

Saraki said that through the collaboration, her organisation aimed to equip healthcare professionals with the skills and knowledge needed to save lives.

The News Agency of Nigeria (NAN) reports that 30 lead faculty members have so far be trained to train others at the center of excellence in Lagos.

The initiative marks a milestone in LSTM’s ongoing efforts to strengthen healthcare systems in Nigeria and beyond. (NAN)(www.nannews.ng)

Edited by Uche Anunne

Asaba Specialist Hospital conducts free health screening for staff

Asaba Specialist Hospital conducts free health screening for staff

By Carol Utulu

The Management of Asaba Specialist Hospital has conducted a comprehensive health screening programme for its staff to promote the well-being of the hospital’s workforce.

Dr Peace Ighosewe, the Chief Medical Director of Asaba Specialist Hospital, who spoke during the exercise in Asaba, said it was designed to ensure that all staff benefitted from the same services offered to patients.

She said that the management prioritised the health and well-being of its staff as the screening was aimed at boosting their morale and productivity as well as commemorating this year’s World Day for Safety and Health at Work.

The screening included medical tests such as fasting lipid profile, electrocardiogram (ECG), eye screening, diabetes screening, prostate-specific antigen (PSA) Test and Breast Self-Examination demonstration.

There was also a lecture series and a staff workout exercise unveiled on May 4, which will henceforth be held on a bimonthly basis.

Ighosewe expressed gratitude to the Gov. Sheriff Oborevwori-led administration for prioritising the welfare of healthcare workers in Delta State and creating conducive environment for the hospital to flourish.

She also extended her appreciation to the Delta State Commissioner for Health, Dr Joseph Onojaeme, for his support and approval of the project.

Ighosewe advised other hospitals to emulate the gesture; showing love and care for their workers’ health and well-being.

She said it would encourage staff to work better and increase harmony among team members.

Dr Ngozi Onwueme, a Consultant Cardiologist, commended the management for organising the exercise, stating that many staff members who benefitted were carrying out the tests for the first time.

She said that new diagnoses were made and treatment had commenced for some staff members.

Staff members who participated in the programme expressed their appreciation for the initiative, which showed that the hospital cared about their well-being.

Ogala Priscilla, a staff member, laude the management for the initiative.

“I want to thank the management for this thoughtful screening exercise; we appreciate their efforts,” she said.

Ngozi Ossai, a cleaner at the hospital, said she was delighted to be a beneficiary of the medical screening.

“I want to thank the management for including me in the screening; I am very grateful,” she said.

On his part, Azubuike Aweni, thanked the management for looking after the well-being of staff members.

“I want to thank the hospital for this kind gesture, most especially the Medical Director, Dr Peace Ighosewe, for her thoughtfulness,’’ he said. (NAN)(www.nannews.ng)

===================
Edited by Ifeyinwa Okonkwo and Chijioke Okoronkwo

NMA reacts to arrest of alleged fake doctor in Lagos

NMA reacts to arrest of alleged fake doctor in Lagos

 

By Oluwafunke Ishola

The Nigerian Medical Association (NMA) has commended the Nigerian Police Force for arresting an alleged fake medical doctor, saying it would strengthen its fight against quackery in the medical profession.

Dr Benjamin Olowojebutu, Chairman, NMA Lagos, said this in an interview with the News Agency of Nigeria (NAN) on Tuesday in Lagos.

Olowojebutu noted that medical quackery was a dangerous practice that posed a threat to the wellbeing of citizens and delivery of quality healthcare in the state, and country.

“The arrest is a welcome development to the health sector; we would expose these quacks and ensure that Lagos does not suffer further morbidity and mortality from their nefarious activities.

“We are glad that our work on anti-quackery has started yielding progress as we are determined to weed out quacks from the medical profession,” he said.

The chairman pledged that NMA Lagos, with support of the Ministry of Health, Health Monitoring and Accreditation Agency (HEFAMAA), and the Police, would eradicate quacks from the state.

He said that the association would hold an Anti-Quackery Summit soon, after which it would present a white paper to the Lagos State Government on anti-quackery.

Olowojebutu warned hospitals to refrain from employing staff whose certificates and licenses had not been verified by the MDCN toward safeguarding the health of the populace.

NAN reports that the Zone 2 Police Command, Onikan, Lagos, on May 7, announced its arrest of a 37-year-old medical practitioner, with suspected forged certificates at Skylink Medical Centre, Elepe-Ikorodu.

The police said it arrested the suspect who claimed to be the Managing Director of the health facility based on intelligence gathered by the command through members of the Elepe community concerning the activities of the suspect.

It said it recovered two suspected forged certificates of Obafemi Awolowo University, Ile-Ife, Osun State and Medical and Dental Council of Nigeria (MDCN) after conducting a search of the facility.

It further revealed that the hospital complex had been sealed, pending the outcome of an ongoing investigation. (NAN)www.nannews.ng

Edited by Vivian Ihechu

UN tasks ASWHAN board on resource mobilisation, strategies to end AIDS

UN tasks ASWHAN board on resource mobilisation, strategies to end AIDS

 

By Justina Auta

The UN Women, UNAIDS and others have called on the newly inaugurated Board of Trustees (BOT) members of Association of Women Living with HIV/AIDS in Nigeria (ASWHAN) to mobilise resources and implement strategies to end AIDS as a public health threat by 2030.

They made the call at a three-day inaugural BOT meeting and resource mobilisation training for management board members and staff on Monday in Abuja.

Ms Patience Ekeoba, the National Programme Officer and Focal Person for HIV/AIDS, UN Women, said that the board members, who have experience on HIV/AIDS, should promote the activities of the association and ensure they became part of decision making in the HIV/AIDS response.

She said “we are hoping that the board will be able to drive resource mobilisation because it has been one of the challenges of the association over the years.

“The board tried a lot in trying to mobilise funds by writing proposals and others in the past. We believe members will be able to bring in their leadership and mobilise funding that they need not just for the national level, but at the state and community levels too.”

Dr Leopold Zekeng, the UNAIDS Country Director, said the inauguration of the BOT would strengthen ASWHAN activities and address the challenges faced by women and girls living with HIV/AIDS.

He said “achieving gender equality, advancing women’s empowerment and fulfilling the sexual and reproductive health and rights of women and girls are crucial to achieving the Sustainable Development Goals and in ending AIDS as a public health threat by 2030.

“Four decades of the HIV response heralded significant success, yet, much more is needed, particularly in terms of ensuring women and girls are not left behind.”

He added that by addressing gender inequalities, patriarchy and discrimination, a society where women and girls are less vulnerable to HIV would be created.

The country director reiterated UNAIDS’s commitment to ensure that women and girls have their rights fulfilled and empowered to protect themselves against HIV with access to treatment, care and support.

On his part, Dr Pat Matemilola, a board member and former Coordinator, Network of People Living with HIV and AIDS in Nigeria (NEPWHAN), pledged the network’s support to the association and to explore other areas like education, nutrition and others that would promote ASWHAN.

He said “the board of trustees will help to broaden views and make ASWHAN not to concentrate too much or narrow the field too much on HIV/AIDS.

“The fact that ASWHAN is under NEPWHAN has become a limiting factor, so once they are able to break free and launch into other areas that are not strictly HIV, they will make a lot of progress.”

Mrs Esther Hindi-Maliki, the National Coordinator of ASWHAN, said with the inauguration of board members, there would be more engagements and advocacies with partners on various thematic areas, apart from HIV/AIDS.

She said “we will mobilise resources because you cannot work without financial and other resources.

“So, we will look for resources to do our interventions and implementations and hopefully the future of ASWHAN will be bright.

“And with this Board of Trustees and cooperation of the management will work to ensure that we implement and intensify sensitisation and advocacies with partners.” (NAN)

Edited by Hadiza Mohammed-Aliyu

Group seeks holistic approach toward addressing determinants of suicide

Group seeks holistic approach toward addressing determinants of suicide

By Lilian U. Okoro

The Nigeria Suicide Prevention Advocacy Group has called for a holistic approach to prevent and address the determinants of suicide in the country.

Dr Oluwatosin Adekeye, Deputy Director, Clinical Psychology, Ahmadu Bello University Teaching Hospital, Zaria, made the call at the 2nd Virtual Meeting of the Group on the topic: “Determinants of Suicidality in Nigeria”.

Adekeye called for the collaborative efforts of all stakeholders to addressing the determinants of suicide, saying that effective prevention and intervention of requires a multilayered approach.

He said that the increasing rate of suicide and its corresponding devastating effects made it pertinent for stakeholders including governments, families, policy-makers and organisations to collectively look at the issue with a view to addressing it.

According to him, suicide is a behaviour motivated by the desire to escape unbearable psychological pain.

He identified psychological risk factors of suicide to include bulling, social rejection, quality of life and lack of care, saying that sadness, anxiety and hopelessness were the key causative factors of suicide in Nigeria.

Adekeye, who called for increased advocacy on suicide, provision of support through prevention and treatment, emphasised the need for decriminalisation of suicide to pave the way for effective suicide prevention and control in Nigeria.

“Effective prevention and intervention require a multilayered approach that encompasses community engagement, healthcare service enhancement and robust policy support.

“Hence, the need for social support system and education of the populace on the psychological determinants of suicide and how to cope with them,” he said.

Speaking, a Consultant Psychiatrist, Prof. Jibril Abdulmalik, identified gender as a biological risk factor for suicide, saying there was a strong genetic history in connection to suicide.

Abdulmalik, an Associate Professor of Psychiatry, UCH Ibadan, said that men were at higher risk of suicide than women.

According to him, men tend to commit suicide four times more than women.

Alhaji Abubakar Bichi, a Social Worker at the Federal Medical Centre, Kano, said that poverty and unemployment had become the major economic factors affecting suicidality in Nigeria.

Bichi, also the National President, Association of Medical Social Workers of Nigerian (AMSWON), said the burden of economic pressures such as debt, inability to meet daily needs and uncertainty about future could lead to increased level of stress and anxiety, leading to suicide.

He decried that mental health services were barely available in the rural communities, as the country only have six Federal Psychiatric hospitals basically located at the urban cities.

“Mental Health, though, might be a long term health condition, is treatable that an individual with the condition can live a normal life.

“Unfortunately, in many Nigeria communities, mental health issues are often stigmatised and perceived as sign of weakness.

“The social and economic determinants are the major causative factors of mental health conditions and suicide in Nigeria, hence the need to address them.

“The Government should implement mental health policies and laws and provide the enabling environment for the citizens to be meaningfully engaged.

“Let there be more job opportunities so that people will gainfully be employed and the basic amenities be made available,” Bichi said.

Prof. Ibrahim Wakawa, Medical Director, Federal Neuro-psychiatric Hospital Maiduguri, said there was need for a public pronouncement by the Federal Ministry of Health that suicide has became a public health pandemic.

According to him, there is need for proper control and monitoring of the means of access to suicide like snipper, by the relevant authorities.

He noted that poverty alleviation needed to be really considered a priority if significant achievement would be made in prevention of suicide in Nigeria.

Earlier, Prof. Taiwo Sheikh, the Group Coordinator, said that mental health, including determinants of suicide, affect millions of people across Africa, adding that stigma and cultural misconceptions often compound these issues.

In his welcome speech, Sheikh, also a consultant psychiatrist, said that insufficient public spending on mental health and suicide prevention was a major barrier to providing assistance to those in need.

According to him, effective suicide prevention can only take place through a whole-of-society approach that involves the government, civil society organisations and community leaders.(NAN)(www.nannews.ng)
Edited by Vivian Ihechu

Beating non-communicable diseases to safeguard African children

Beating non-communicable diseases to safeguard African children

 

 

By Vivian Ihechu, News Agency of Nigeria (NAN)

Emeka Ahanonu and Ugo Alilionwu are from the same family. Following frequent hospital admissions in early childhood, they were later diagnosed with sickle cell disease.

Their family, living in a village in the eastern part of Nigeria, did as much as they could to manage their condition.

With time, cost of medication and care became burdensome for the poor family, coupled with the rising cost of living.

Meeting up with medications, hospital appointments, adequate nutrition and observing other conditions necessary to manage the condition became tougher.

Sadly, Ahanonu and Alilionwu passed on within an interval of about four years, at the ages of 11 and 14,  respectively.

In a related development, Chisom Chukwuneke, 17, who was the best candidate in the 2019 West African Senior Secondary Certificate Examination  in her school, died after a battle with blood cancer.

At her demise, her father, Mr Felix Chukwuneke,  wrote, “As restless and worried as I can be, I promised to do everything humanly possible. We went to South Africa. We were happy at your initial recovery, not knowing the war was just to begin.”

Young Chukwuneke  died in 2020.

Again, Onome Eka’s family got to know she had Type 1 Diabetes when was 12 years old.

Keeping up with her treatment with insulin was an ordeal. It was expensive. Payment was out of the pocket. Getting needed treatment as and when due was difficult. Thus, Eka passed away some months later.

However, Akida Abdul, 10, and Emmanuel Anga,15, of Kondoa District in Tanzania have been able to live with SCD and Type 1 Diabetes respectively, having access to a PEN-Plus clinic in their community.

In spite of their families’ lack of funds for their treatments, the clinic has been able to bridge the gaps in financing, accessibility and other issues that could have limited them from having access to care.

The World Health Organization (WHO) approach to addressing severe Non-Communicable Diseases (NCDs) through an integrated outpatient service at first-level hospitals is called integrated PEN-Plus (package of essential interventions for severe NCDs).

It  aims to mitigate the  burden of severe NCDs among the poorest children and young adults by increasing  accessibility particularly  in  low and middle-income countries.

On Aug. 23, 2022,  the 47 member-states of the WHO/Afro region voted to adopt PEN-Plus strategy to address severe NCDs at first-level referral facilities.

According to WHO, NCDs such as cancer, cardiovascular diseases and diabetes, are increasingly becoming the main cause of mortality in sub-Saharan Africa.

NCDs, also known as chronic diseases, are non-transmissible diseases of often long duration. Examples of NCDs include mental health conditions, stroke, heart disease, cancer, diabetes, sickle cell disorder, and chronic lung disease.

They are driven largely by behaviours that usually start during childhood and adolescence. Such behaviours include physical inactivity, unhealthy diet, tobacco use and harmful use of alcohol.

However, sometimes, they are genetic or congenital.

The diseases are accountable for 37 per cent of deaths in 2019, rising from 24 per cent in 2000 largely due to weaknesses in the implementation of critical control measures including prevention, diagnosis and care.

In Africa, between 50 per cent and 88 per cent of deaths in seven countries, mostly small island nations, are due to non-communicable diseases, according to the 2022 World Health WHO NCDs Progress Monitor.

Globally, it is estimated that one in two disability-affected lives and one in five deaths among adolescents are caused by NCDs.

In the Africa, the number of people living with diabetes, for example, is expected to reach 47 million by 2045, up from 19 million in 2019.

“The growing burden of NCDs poses a grave threat to the health and lives of millions of people in Africa: over a third of deaths in the region are due to these illnesses.

“What is particularly concerning is that premature deaths from non-communicable diseases are rising among people younger than 70 years,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

Highlighting the gravity of the situation, Moeti, who joined the International Conference on PEN-Plus in Africa (ICPPA2024) virtually, said it was time to prioritise person-centred approach to NCDs.

The four-day conference, from April 23 to  April 25, 2024, had the theme, “Prioritising Person-Centered Approach to Chronic and Severe NCDs – Type 1 Diabetes, Sickle Cell Diseases, and Childhood Heart Diseases.”

It was hosted by the Tanzania Ministry of Health and the World Health Organization African Region (WHO-Afro), in partnership with the HELMSLEY Charitable Trust and NCDI Poverty Network.

The meeting centred around  inequitable access to prevention, diagnosis, treatment and ongoing care, seeking commitment to advocate increased focus on chronic and severe non-communicable diseases within existing healthcare delivery systems.

Moeti said: “The surge in the number of NCDs on our continent over the past two decades is driven by increasing incidences of risk factors, such as unhealthy diets, reduced mental activity, obesity, and air pollution.”

She urged African governments to step up efforts and embrace the PEN-Plus initiative to ensure that targets would be met.

“Severe NCDs such as Type 1 Diabetes, rheumatic heart disease and sickle cell disease, more frequently affect children and young adults, the majority of Africa’s population.

“Africa must invest more now in addressing NCDs with adequate and sustained resources.

“We are continuing to invest in reducing the high burden of premature mortality from chronic and severe disease within the context of Universal Health Coverage.

“Despite our member-states’ efforts, we have a huge challenge in NCDS in Africa,” she said.

According to the official, data from low-income countries shows that 26 per cent of total health spending is due to NCDs, second only to infectious and parasitic diseases.

“This means it is urgent to give these often-neglected diseases the priority and attention they deserve.’’

She said that the rapid evolution with a higher mortality rate had not been adequately recognised because of inadequate investment and lack of diligence in knowing the diseases.

Also, Elke Wisch, UNICEF Representative in Tanzania, who represented the UN Resident Coordinator in Tanzania, noted that children had become at great risk of NCDs.

“Beyond the general picture of NCDs, we also have severe conditions that pose acute stages in individuals affected by these conditions.

“Diseases such as sickle cell anemia, rheumatic heart diseases and Type 1 Diabetes do not only affect adults but also impact children and adolescents in significant numbers here, in Tanzania, and other countries in Africa.’’

Wisch said that the diseases, if not priority attention, would remain a cause of mortality in children and adolescents.

“The United Nations system is consciously aware of the profound impact that NCDs have on individuals, families and entire societies and nations.

“These diseases, including cardiovascular diseases, cancer diabetes and chronic respiratory diseases, pose significant challenges to our healthcare systems and the well-being of our countries.”

Recognising the gravity of the consequences of not addressing NCDs, especially for children and adolescents, Mr James Reid of Helmsley Charitable Trust, suggested ways to address the situation.

He advised that all efforts and investments in addressing NCDs should be focused on integrating NCD care seamlessly into existing health systems.

“The key to achieving UHC lies in expanding primary healthcare, especially in low-resource and humanitarian settings.

“Collaborative, cross-sector strategies, innovative investments and a focus on integrating NCD care into existing health systems are all keys to achieving health for all,’’ he said.

He said that successful models such as PEN-Plus had demonstrated the effectiveness of empowering nurses and mid-level providers to integrate NCD care into the ongoing continuum of primary healthcare.

Through the PEN-Plus initiative, governments in the African region are working on strengthening preventive measures, promoting healthy lifestyles and ensuring access to quality healthcare services at the primary healthcare levels where many people seek healthcare services.

Also, SDG 3.4 calls for all member-states to reduce premature deaths from NCDs by one-third in 2030 through prevention, treatment and promoting mental health and well-being.

However, a number of low- and middle-income countries are not on track to actualising SDG target 3.4 to reduce NCD mortality.

From the Africa Centres for Disease Control and Prevention (Africa CDC), the same indices resonate, with NCDs and other conditions rising and threatening the continent’s vision of achieving and building an integrated, prosperous and peaceful Africa driven by its own citizens.

However, as highlighted in the AU Agenda 2063, addressing the menace will also involve addressing these conditions with a multi-faceted approach.

Dr Mohammed Abdulaziz, Head, Division of Disease Control and Prevention, Africa CDC, affirmed that a multi-faceted and integrated approach to solving some of the major health system obstacles in the delivery of NCDs Treatment and Prevention and Control Plan, was needed.

“Our approach must prioritise the individual and families impacted by NCDs.

“We must ensure equitable access to essential medicines and services for everyone for everyone.’’

According to him, as agreed by the AU heads of state, there is need to set up a pool procurement mechanism to strengthen and see if this will help in getting essential medication and access to health products for these high-burden diseases.

Also, he stressed the need for the integration of data which should be collected nationally, through surveillance.

Achieving these goals, he said, also required bridging the funding gap for Africa for the NCDs programmes across the continent.

“We have no choice but to also push for domestic finance. We know that very few of our countries are reaching the 15 per cent mark budget for health, the Abuja declaration.

“If we can show to all what we are doing, that our government should, in putting more funding into health, put more in the area of NCDs, it will be good to help us reach that target’’.

In conclusion, the path ahead toward addressing NCDS requires collaboration, communication, innovation and a human-centred approach.

There is need for increased investment toward prevention, research and care for childhood NCDs, with access to equitable care and support given priority attention, leaving no one behind.

These can be achieved when governments and leaderships are committed to stepping up efforts and embracing initiatives such as the PEN-Plus initiative, to ensure that targets are met.

In so doing, aside adults, African children and adolescents can hope for a brighter future without the scare of living with or sliding into eternity with NCDS, when it could have been prevented or optimally-managed.

At present, 20 countries in Sub-Saharan Africa are at various stages of initiating, implementing or scaling up PEN-Plus.

It is estimated that no fewer than 10,000 people are receiving treatment for severe NCDs in PEN-Plus Clinics across 11 Sub-Saharan countries.

By 2030, the WHO’s goal is for 70 per cent of African region member-tates to have national plans for integrated care, NCD training for health workers, and essential medicines in district hospitals. (NANFeatures)

Edited by Ijeoma Popoola

*** If used, please credit the writer and the agency **

X
Welcome to NAN
Need help? Choose an option below and let me be your assistant.
Email SubscriptionSite SearchSend Us Email